Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 14, 2026 16:07 ET | Source: Cue Biopharma, Inc.

Cue Biopharma Reports First Quarter 2026 Financial Results and Recent Strategic Developments

Enhanced the company’s portfolio with an exclusive license for, CUE-221, a Phase 2 program targeting allergic disease Hosted virtual R&D day showcasing CUE-401, a bifunctional IL-2 and TGF-B...
May 14, 2026 16:05 ET | Source: Sutro Biopharma, Inc.

Sutro Biopharma Reports First Quarter 2026 Financial Results and Business Highlights

– On track to report initial safety, PK and early activity from Phase 1 dose-escalation trial of STRO-004, potential best-in-class Tissue Factor ADC, in mid-2026 – – Continued advancement of...
May 14, 2026 16:05 ET | Source: Mannatech Inc

Mannatech Reports Financial Results for First Quarter 2026

FLOWER MOUND, Texas, May 14, 2026 (GLOBE NEWSWIRE) -- Mannatech, Incorporated (NASDAQ: MTEX), ("Mannatech" or "Company"), global health and wellness company committed to transforming lives to make...
May 14, 2026 16:05 ET | Source: CapsoVision

CapsoVision Reports First Quarter 2026 Financial Results

SARATOGA, Calif., May 14, 2026 (GLOBE NEWSWIRE) -- CapsoVision, Inc. (NASDAQ: CV), a commercial-stage medical technology company developing advanced imaging and AI-enabled capsule endoscopy...
May 14, 2026 16:05 ET | Source: Artelo Biosciences

Artelo Biosciences Provides Business Update Outlining Upcoming Milestones and Reports 2026 First Quarter Financial Results

SOLANA BEACH, Calif., May 14, 2026 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL) (“Artelo” or the “Company”), a clinical-stage pharmaceutical company focused on modulating...
May 14, 2026 16:01 ET | Source: Sangamo Therapeutics, Inc.

Sangamo Therapeutics Reports Recent Business Highlights and First Quarter 2026 Financial Results

Sangamo Therapeutics reports first quarter 2026 business updates and financial results
May 14, 2026 15:30 ET | Source: Custom Market Insights

[Latest] Global Dental Collagen Membranes Market Size/Share Worth USD 0.86 Billion by 2035 at a 7.1% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

Austin, TX, USA, May 15, 2026 (GLOBE NEWSWIRE) -- Healthcare Foresights has published a new research report titled “Dental Collagen Membranes Market Size, Trends and Insights By Source (Bovine...
May 14, 2026 13:00 ET | Source: DelveInsight Business Research LLP

Global Cervical Cancer Diagnostics Market to Exhibit Growth at a CAGR of ~5% by 2034 | DelveInsight

New York, USA, May 14, 2026 (GLOBE NEWSWIRE) -- Global Cervical Cancer Diagnostics Market to Exhibit Growth at a CAGR of ~5% by 2034 | DelveInsight The cervical cancer diagnostics market is...
May 14, 2026 12:30 ET | Source: Custom Market Insights

[Latest] Global Transgenic Animals Market Size/Share Worth USD 7.89 Billion by 2035 at a 10.1% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

Austin, TX, USA, May 14, 2026 (GLOBE NEWSWIRE) -- Healthcare Foresights has published a new research report titled “Transgenic Animals Market Size, Trends and Insights By Type (Mice, Rats, Rabbits,...
May 14, 2026 10:45 ET | Source: MarketsandMarkets Research Pvt. Ltd.

Global Digital Stethoscopes Market Set to Reach USD 717.3 Million by 2032 | MarketsandMarkets™

Delray Beach, FL, May 14, 2026 (GLOBE NEWSWIRE) -- The global digital stethoscopes market is entering a pivotal growth phase, projected to expand from USD 491.7 Million in 2025 to USD 717.3 Million...